Skip to main content
Premium Trial:

Request an Annual Quote

New Mutation Implicated in Ovarian Cancer


British researchers have found that women who carry a mutated copy of the RAD51D gene have a one in 11 chance of developing ovarian cancer, reports Reuters' Kate Kelland. The researchers, who recently published their study in Nature Genetics, compared the DNA of women from 911 families with breast and ovarian cancer to DNA from a control group and found eight "faults" in the RAD51D gene of the cancer patients compared with only one in the control group, Kelland says. Previous studies had already shown that mutated RAD51D is sensitive to PARP inhibitors. The study's senior author tells Kelland that this discovery may lead to the use of PARP inhibitors to treat women with mutated RAD51D ovarian cancer.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.